Tofacitinib and faecal microbiota transplantation in treating checkpoint inhibitor-induced enterocolitis: case report
Background Immune checkpoint inhibitors (ICIs) can induce a wide range of immune-related adverse events (irAEs), potentially affecting any organ. ICI-induced colitis is a frequently reported irAE, whereas enteritis is rare and not well documented.Case presentation We are presenting a patient with me...
Main Authors: | Jakob Benedict Seidelin, Inge Marie Svane, Eva Ellebaek, Henrik Vedel Nielsen, Emilie Kristine Dahl, Morten Helms, Rikke Boedker Holmstroem, Jacob Tveiten Bjerrum, Janne Bayer Andersen |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2022-03-01
|
Series: | BMJ Open Gastroenterology |
Online Access: | https://bmjopengastro.bmj.com/content/9/1/e000989.full |
Similar Items
-
Lipidomic trajectories characterize delayed mucosal wound healing in quiescent ulcerative colitis and identify potential novel therapeutic targets
by: Bjerrum, Jacob Tveiten, et al.
Published: (2022) -
Antibiotics in the medical and surgical treatment of necrotizing enterocolitis. A systematic review
by: Ester Maria Gill, et al.
Published: (2022-01-01) -
Arginase-1 targeting peptide vaccine in patients with metastatic solid tumors – A phase I trial
by: Cathrine Lund Lorentzen, et al.
Published: (2022-10-01) -
Comparative onset of effect of biologics and small molecules in moderate-to-severe ulcerative colitis: a systematic review and network meta-analysisResearch in context
by: Mohamed Attauabi, et al.
Published: (2023-03-01) -
Tofacitinib
by: Nilgün Şentürk
Published: (2022-04-01)